For patients with NAFLD and obesity, the AUROCs of APRI, FIB-4, and GPR in predicting significant fibrosis were 0.623, 0.603, and 0.637, respectively. This evidence concerns the gene ALDH18A1 and metabolic dysfunction-associated steatotic liver disease.